期刊文献+

Lp(a)对THP-1源性巨噬细胞基质金属蛋白酶和基质金属蛋白酶抑制剂表达和活性的影响 被引量:1

Lipoprotein(a) Differentially Regulates Matrix Metalloproteinses and Tissue Inhibitors of Matrix Metalloproteinase in THP-1-Derived Macrophages. Novel Implications for Atherogenesis
下载PDF
导出
摘要 目的通过研究脂蛋白a对巨噬细胞源性基质金属蛋白酶(MMPs)和基质金属蛋白酶内源性组织拟制剂(TIMPs)表达的调节作用,探讨脂蛋白a促动脉粥样硬化的机制。方法利用从新鲜混合血浆经超速离心和亲和层析纯化的脂蛋白a刺激人单核细胞白血病THP_1细胞经豆蔻酰佛波醇乙酯诱导24 h转化而成的巨噬细胞,孵育10 h和36 h后收集细胞裂解液和条件培养基分别进行MMPs/TIMPs mRNA和蛋白检测及明胶酶谱分析MMPs活性。结果免疫印迹结果显示脂蛋白a可使巨噬细胞培养基中MMP_1、MMP_2、MMP_9、MT1_MMP水平明显上调,其中MMP_2和MT1_MMP的活性形式明显增加;而其抑制剂TIMP_1、TIMP_2水平则明显减少,以前者的剂量效应最为明显。明胶酶谱分析表明条件培养基中MMP_9活性增强。逆转录聚合酶链式反应结果显示,MMP_1、MMP_2、MMP_9 mRNA水平随Lp(a)刺激增强而增加,TIMP_1 mRNA水平则梯度降低,而MT1_MMP、TIMP_2的mRNA水平未见明显改变。结论研究发现Lp(a)可促进巨噬细胞表达多种MMPs,同时抑制TIMPs的表达,由此所致的MMPs/TIMPs表达及活性失衡最终可致基质过度降解,在整体情况下则可能促进斑块进展成不稳定斑块并破裂。为阐明Lp(a)的促动脉粥样硬化机制提供了新的线索。 Objective Maerophage-derived matrix metalloproteinases (MMPs) and endogenous tissue inhibitors of matrix metalloproteinase (TIMPs) play a central role in atherosclerotic plaque enlargement and its ultimate rupture. Lipoprotein(a) [ Lp (a)] deposits in macrophage-rich plaques are correlated with acute coronary syndrome. We hypothesized that Lp(a) might regulate the expression of MMPs and 'liMPs in macrophages. Methods Macrophages were obtained by transforming THP-1 cell line with phorbol 12-myristate 13-acetate (PMA). The THP-1-derived macrophages were exposed to Lp(a) (5 - 20 μg/mL) for 36 hours, and the production of MMP-1, MMP-2, MMP-9 and membrane type 1-MMP (MT1-MMP), and the expression of TIMP-1 and TIMP-2 were assayed by Western blot and gelatin zymography. Results The exposure of THP-1-derived macrophages to Lp (a) (5 - 20 μg/mL) for 36 hours increased the production of MMP-1, MMP-2, MMP-9, and membrane type 1-MMP, and suppressed the expression of TIMP-1 along with the changes of Lp(a) dosage, as indicated by Western blot and gelatin zymography. Reverse transcription-polymerase chain reaction (RT-PCR) revealed that alterations in protein production of MMP-1, MMP-2, MMP-9 and TIMP-1 mainly resulted from changes of mRNA transcription. Conclusions Lp(a) induces abnormal expression/activity of MMPs and TIMPs in THP-1 macrophages. The present study put forward the possibility that Lp(a) might contribute to plaque vulnerability and consequent rupture in atherosclerosis.
出处 《中国比较医学杂志》 CAS 2006年第12期710-715,共6页 Chinese Journal of Comparative Medicine
基金 科技部国家重大基础项目(973)(2006CB503805) 科技部公益基金项目(2004DIA1J001)
关键词 脂蛋白a巨噬细胞 基质金属蛋白酶 动脉粥样硬化 斑块 Lipoprotein(a) Macrophage Metalloproteinase Plaque Atherosclerosis
  • 相关文献

参考文献22

  • 1Holmer SR,Hengstenberg C,Kraft HG,et al.Association of polymorphisms of the apolipoprotein (a) gene with lipoprotein (a)levels and myocardial infarction[J].Circulation,2003,107:696 -701. 被引量:1
  • 2Sun L,Li Z,Zhang H,et al.Pentanucleotide TTTTA repeat polymorphism of apolipoprotein (a) gene and plasma lipoprotein (a)are associated with ischemic and hemorrhagic stroke in Chinese:a multicenter case-control study in China[J].Stroke,2003,34:1617-1622. 被引量:1
  • 3Ariyo AA,Thach C,Tracy R.et al.Lp (a) lipoprotein,vascular disease,and mortality in the elderly[J].N Engl J Med,2003,349:2108-2115. 被引量:1
  • 4Haque NS,Zhang X,French DL,et al.CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells[J].Circulation,2000,102:786 -792. 被引量:1
  • 5Haque NS,Fallon JT,Pan JJ,et al.Chemokine receptor-8 (CCR8)mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion[J].Blood,2004,103:1296-1304. 被引量:1
  • 6Dangas G,Mehran R,Harpel PC,et al.Lipoprotein (a) and inflammation in human coronary atheroma:association with the severity of clinical presentation[J].J Am Coll Cardiol,1998,32:2035-2042. 被引量:1
  • 7Galis ZS,Khatri JJ.Matrix metalloproteinases in vascular remodeling and atherogenesis:the good,the bad,and the ugly[J].Circ Res,2002,90:251-262. 被引量:1
  • 8Aikawa M,Rabkin E,Sugiyama S,et al.An HMG-CoA reductase inhibitor,cerivastatin,suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro[J].Circulation,2001,103:276-283. 被引量:1
  • 9Yoon SO,Park SJ,Yoon SY,et al.Sustained production of H(2)O(2) activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-kappa B pathway[J].J Biol Chem,2002,277:30271-30282. 被引量:1
  • 10Fortunato JE,Bassiouny HS,Song RH,et al.Apolipoprotein (a)fragments in relation to human carotid plaque instability[J].J Vasc Surg,2000,32:555-563. 被引量:1

同被引文献6

  • 1Kato R,Momiyama Y,Ohmori R,et al.Levels of Matrix metalloproteinase-1in Patients With and Without Coronary Artery Disease a. 被引量:1
  • 2Tanindi A,Sahinarslan A,Elbeg S,et a1.Relationship Between MM P-1,MM P-9,TIM P-1,I L-6 and Risk Factors,Clinical Presentati. 被引量:1
  • 3Bostom AG,Gag non DR,Cupples LA,et al.A prospective investigation of elevated Lipoprotein(a)detected by electrophoresis and. 被引量:1
  • 4Dangas G,Meh ran R,Har pel PC,et a1.Lipoprotein(a)and inflammation in human coronary atheroma:association with the severity. 被引量:1
  • 5Ashfaq F,Goel PK,Moorthy N,et a1.Lipoprotein(a) and SYNTAX Score Association with Severity of Coronary Artery Atheroscleros. 被引量:1
  • 6Fortunato JE,Bassiouny HS,Song RH,et a1.Apolipoprotein(a)fragments in relation to human carotid plaque instability[J].J Vas. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部